TY - THES 
AU - Rios Rodriguez, Valeria
PY - 2023
UR - https://hdl.handle.net/20.500.12880/7413
AB - Background Dysbiosis of the gut microbiota might be associated with the development and progression of axial spondyloarthritis (axSpA). Biological disease-modifying antirheumatic drugs (bDMARDs) effectively treat axSpA, but non-response to therapy...
LA - eng
TI - Improvement of the gut microbiota balance in patients with axial spondyloarthritis after one year of biological therapy
KW - Spondyloarthritis
KW - Microbiota
KW - bDMARDs
KW - 16S rRNA
KW - Biomarker
ER -